ATRenew (NYSE: RERE) CFO Chen Chen reports options and ADS stake
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ATRenew Inc. director and Chief Financial Officer Chen Chen filed an initial Form 3 showing existing equity holdings in the company. The filing lists multiple option grants over Class A ordinary shares with a $0.10 exercise price and expiration dates ranging from 2030 to 2035. It also reports direct ownership of 34,174 American depositary shares. A footnote states that every three ADS represent two Class A ordinary shares, clarifying how the ADS relate to the underlying equity.
Positive
- None.
Negative
- None.
Insider Trade Summary
16 transactions reported
Mixed
16 txns
Insider
Chen Chen
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | Options (Right to Buy) | -- | -- | -- |
| holding | American depositary shares | -- | -- | -- |
Holdings After Transaction:
Options (Right to Buy) — 181,668 shares (Direct);
American depositary shares — 34,174 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What does Chen Chen report in the ATRenew (RERE) Form 3 filing?
Chen Chen reports existing equity holdings in ATRenew, including multiple stock option grants and directly held American depositary shares. The Form 3 establishes Chen’s initial beneficial ownership as a director and Chief Financial Officer, rather than disclosing new purchases or sales of securities.
What stock options does Chen Chen hold in ATRenew (RERE)?
Chen Chen holds several option awards over ATRenew Class A ordinary shares, each with a $0.10 exercise price and various expiration dates between 2030 and 2035. These option positions provide the right to buy underlying Class A ordinary shares at that fixed price.
Are there any reported insider stock purchases or sales in this ATRenew (RERE) Form 3?
The Form 3 does not show any insider stock purchases or sales. Instead, it classifies the entries as holdings, summarizing Chen Chen’s existing options and ADS position at the time of becoming a reporting insider, with transaction direction fields marked as unknown.
What is the significance of the $0.10 exercise price in Chen Chen’s ATRenew (RERE) options?
Each disclosed stock option grant carries a $0.10 exercise price per underlying Class A ordinary share. This means Chen can acquire shares at that fixed price before the respective expiration dates, subject to any vesting or other conditions not detailed here.